ECI TECH (08013) announced its interim performance. Shareholders' attributable profit increased by 44.65% year-on-year to HK$6.57 million.
ECI TECH (08013) released its interim performance for the six months ending on February 28, 2026. The group achieved revenues of HK$121 million, an increase of 21.64% year-on-year; a net profit of HK$6.57 million, an increase of 44.65% year-on-year; and earnings per share of 0.411 HK cents.
ECI TECH (08013) released its interim performance for the six months ending on February 28, 2026. The group achieved a revenue of HK$121 million, an increase of 21.64% year-on-year. The profit for the period was HK$6.57 million, an increase of 44.65% year-on-year, with a basic earnings per share of 0.411 HK cents.
Related Articles
US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.
JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.
SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
US Stock Market Move | Q1 performance exceeds expectations Intuitive Surgical, Inc. (ISRG.US) rose more than 8% in early trading.
JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.
SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
RECOMMEND
DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026
48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026
Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026
